Active
TERM 1
January 24, 2025 · 534 days ago
🏥 Healthcare
On January 24, 2025, President Trump signed Executive Order 14182 directing federal agencies to enforce the Hyde Amendment, which prohibits federal funds from being used to pay for abortion services except in cases of rape, incest, or danger to the mother's life. The order requires agencies to withhold federal funding from any organization that provides, refers for, or covers abortion services. The confirmed direct impact includes potential loss of federal funding for Planned Parenthood and other healthcare providers that offer abortion services alongside other medical care.
Active
TERM 2
January 23 2025 · 535 days ago
🏥 Healthcare
The Trump administration reversed its policy allowing federal funds for purchasing and distributing fentanyl detection strips used to test street drugs for contaminants. The Substance Abuse and Mental Health Services Administration issued guidance ending the practice as part of the administration's opposition to harm reduction initiatives. This change eliminates access to potentially life-saving drug testing resources for vulnerable populations.
Active
TERM 2
January 23 2025 · 535 days ago
🏥 Healthcare
Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana to a less-dangerous drug category under federal law. The change impacts federal regulation of marijuana in dozens of states that permit medical use, though it does not fully legalize marijuana federally. This significantly alters how the drug is regulated and enforced at the federal level.
Pending
TERM 2
January 23 2025 · 535 days ago
🏥 Healthcare
President Trump selected Erica Schwartz, former deputy surgeon general and medical doctor, to lead the Centers for Disease Control and Prevention. Schwartz, a retired rear admiral in the U.S. Public Health Service Commissioned Corps, requires Senate confirmation. The CDC has been without permanent leadership for eight months.
Active
TERM 2
January 2025 · 536 days ago
🏥 Healthcare
The Federal Trade Commission and four states filed suit against the World Professional Association for Transgender Health, alleging deceptive claims about gender-affirming care for minors. The action targets medical professionals and organizations providing transgender healthcare services. This represents a coordinated federal and state effort to restrict access to gender-affirming medical care for transgender youth.
Active
TERM 2
January 2025 · 537 days ago
🏥 Healthcare
The Trump administration froze millions of dollars in federal funding for New York's Medicaid Fraud Control Unit (MFCU), which investigates and prosecutes healthcare provider fraud and patient abuse in Medicaid facilities. The action eliminates dedicated enforcement capacity for detecting fraud and protecting vulnerable patients in state Medicaid programs. New York loses federal resources for healthcare oversight and fraud prevention affecting thousands of Medicaid beneficiaries.
Active
TERM 2
January 21 2025 · 537 days ago
🏥 Healthcare
The FDA appointed Katherine Szarama as acting director of the Center for Biologics Evaluation and Research, replacing Vinay Prasad. This unit regulates vaccines and biological products for human use. The leadership change may impact vaccine approval processes and biological product oversight.
Active
TERM 1
January 20, 2025 · 538 days ago
🏥 Healthcare
On January 20, 2025, President Trump signed Executive Order 14155 directing the withdrawal of the United States from the World Health Organization. The order initiates the process to cease U.S. participation in the WHO and discontinue financial contributions to the organization. The direct impact includes halting U.S. funding to WHO programs and ending American involvement in WHO decision-making and global health coordination mechanisms.
Active
TERM 2
January 18 2025 · 540 days ago
🏥 Healthcare
President Trump signed an executive order directing the FDA to accelerate review of psychedelic drugs including ibogaine for medical treatment. The order aims to speed access to psychedelic-based therapies, particularly for treating post-traumatic stress disorder in military veterans. The reform could expand availability of these treatments to Americans seeking alternative mental health interventions.
Active
TERM 2
January 18 2025 · 540 days ago
🏥 Healthcare
President Trump signed an executive order to accelerate research on psychedelic drugs for treating mental health disorders. The order aims to expedite clinical trials and regulatory pathways for these substances. This could expand treatment options for Americans suffering from depression, PTSD, and other mental health conditions.